Prellis Biologics' Series A Round

Prellis Biologics raised a round of funding on June 23, 2017. Investors include SOSV.

Prellis Biologics is developing technology to 3D print engineered human tissues and organs. With its sub-micrometer printing resolution, Prellis Biologics can create single layers of cells and build t…

Articles about Prellis Biologics' Series A Round: